1Glenner GG, Wong CW. Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein.Biochem Biophys Res Commun, 1984, 120: 885-890.
2Masahiro O, Kuang MP, Hou C, et al. Benzofurande derivatives Aβ-aggregate-specific imaging agents for Alzheimer's disease. Nucl Med Biol,2002, 29: 633-642.
3Bacskai BJ, Klunk WE, Mathis CA, et al. Imaging amyloid-β deposits in vivo. J Cereb Blood Flow Metab, 2002, 22: 1035-1041.
4Zhen WG, Han HY, Anguiano M, et al. Synthesis and amyloid binding properties of rhenium complex: preliminary progress toward a reagent for SPECT imaging of Alzheimer's disease brain. J Med Chem, 1999, 42:2805-2815.
5Han H, C heon GC, Peter T, et al. Technetium complex for the quantitation of brain amyloid. J Am Chem Soc, 1996, 118: 4506-4507.
6Ashburn TT, Han H, McG, uinness BF, et al. Amyloid probes based on congo red distinguish between fibrils comprising different peptides. Chem Biol, 1996, 3: 351-358.
7Nancy A, Dezutter RJ. 99Tcm-MAMA-chrysamine G, a probe for betaamyloid protein of Alzheimer's disease. Eur J Nucl Med, 1999, 26:1392-1399.
8Styren SD, Hamilton RL, Styren GC, et al. X-34, a fluorescent derivative of congo red: a novel histochemical stain for Alzeimer's disease pathology. J Histochem Cytochem, 2000, 48: 1223-1232.
9Skovronsky DM, Bin ZH, Kung MP, et al. Imaging Aβ plaques in living transgenic mice with multiphoton microscopy and methoxy-X04, a systemically administered Congo red derivative. J Neurqathol Exp Neurol,2002, 61: 797-805.
10Skovronsky DM, Zhang B, Kung MP,et al. In vivo detection of amyloid plaques in a mouse model of Alzheimer's disease. Proc Natl Acad Sci USA, 2000, 97: 7609-7614.
2Chen YW, Lee MJ,Smith EE.Cerebral amyloid angiopathy in East and West[J].Int J Stroke,2010,5(5):403-411.
3Shi J,Yang SH,Stubley L,et.al.Hypoperfusion induces over expression of beta-amyloid precursor protein mRNA in a focal is Chemic Rodent model [J].Brain Res,2000,853(1): 1-4.
